EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length

Olga G Ovchinnikova, Logan P Treat iD, Tanisha Teelucksingh, Bradley R Clarke iD, Taryn A Miner, Chris Whitfield iD, Kimberly A Walker, Virginia L Miller iD

mBio · 2023

DOI: 10.1128/mbio.00800-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Olga G Ovchinnikova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Cross Infection, Klebsiella Infections. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health, Gouvernement du Canada | Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by Klebsiella pneumoniae continue to be a global public health threat; the treatment of these infections is complicated by the high frequency of multidrug resistance. K. pneumoniae produces a polysaccharide capsule required for virulence. Hypervirulent isolates also have a hypermucoviscous (HMV) phenotype that increases virulence, and we recently demonstrated that a horizontally acquired gene, rmpD , is required for HMV and hypervirulence but that the identity of the polymeric product(s) in HMV isolates is uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross InfectionKlebsiella InfectionsHumansEscherichia coliVirulenceVirulence FactorsKlebsiella pneumoniaeAnti-Bacterial AgentsPolysaccharides

Stichwörter der Autor:innen

KlebsiellaRmpDWzccapsulecapsule chain lengthhypermucoviscosityhypervirulent

Substanzen

Virulence FactorsAnti-Bacterial AgentsPolysaccharides

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
  • Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

ORCID-Profile: Logan P Treat, Bradley R Clarke, Chris Whitfield, Virginia L Miller

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health
  • Gouvernement du Canada | Canadian Institutes of Health Research

Zitieren

APA

Ovchinnikova, O. G., Treat, L. P., Teelucksingh, T., Clarke, B. R., Miner, T. A., Whitfield, C., Walker, K. A., & Miller, V. L. (2023). Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length. mBio. https://doi.org/10.1128/mbio.00800-23

Vancouver

Ovchinnikova OG, Treat LP, Teelucksingh T, Clarke BR, Miner TA, Whitfield C, et al. Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length. mBio. 2023. doi:10.1128/mbio.00800-23

BibTeX
@article{Ovchinnikova2023,
  author = {Ovchinnikova, Olga G and Treat, Logan P and Teelucksingh, Tanisha and Clarke, Bradley R and Miner, Taryn A and Whitfield, Chris and Walker, Kimberly A and Miller, Virginia L},
  title = {Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.00800-23}
}
Kostenlos starten →